Advisors Asset Management, Inc. Abbott Laboratories Transaction History

Advisors Asset Management, Inc.

$5.1 Billion
Q1 2024

A detailed history of Advisors Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 95,713 shares of ABT stock, worth $9.88 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

95,713

Previous 112,389 14.84%

Holding current value

$9.88 Million

Previous $12.4 Million 12.06%

% of portfolio

0.21%

Previous 0.26%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $1.83 Million - $2.02 Million	-16,676 Reduced 14.84%	95,713 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.9 Million - $2.33 Million	-21,064 Reduced 15.78%	112,389 $12.4 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2.53 Million - $2.82 Million	-25,149 Reduced 15.86%	133,453 $14.5 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $1.91 Million - $2.25 Million	-19,748 Reduced 11.07%	158,602 $16.1 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1.9 Million - $2.22 Million	-19,944 Reduced 10.06%	178,350 $19.6 Million

Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $1.64 Million - $1.9 Million	-16,931 Reduced 7.87%	198,294 $19.2 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $1.16 Million - $1.4 Million	-11,348 Reduced 5.01%	215,225 $23.4 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $7,297 - $8,898	-64 Reduced 0.03%	226,573 $26.8 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $1.21 Million - $1.48 Million	10,490 Added 4.85%	226,637 $31.9 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $797,954 - $882,770	6,840 Added 3.27%	216,147 $25.5 Million
Q2 2021 Jul 30, 2021	SELL	$105.79 - $124.53 $616,226 - $725,387	-5,825 Reduced 2.71%	209,307 $24.3 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $625,394 - $736,809	-5,746 Reduced 2.6%	215,132 $25.8 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $261,765 - $285,249	-2,493 Reduced 1.12%	220,878 $24.2 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $780,406 - $947,745	-8,516 Reduced 3.67%	223,371 $24.3 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $323,891 - $414,540	-4,230 Reduced 1.79%	231,887 $21.2 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $74,692 - $109,221	-1,189 Reduced 0.5%	236,117 $18.6 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1.28 Million - $1.43 Million	16,324 Added 7.39%	237,306 $20.6 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $928,638 - $1.01 Million	11,347 Added 5.41%	220,982 $18.5 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $1.61 Million - $1.88 Million	22,134 Added 11.8%	209,635 $17.6 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $1.42 Million - $1.72 Million	21,454 Added 12.92%	187,501 $15 Million
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $1.27 Million - $1.43 Million	19,300 Added 13.15%	166,047 $12 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $510,743 - $616,150	8,399 Added 6.07%	146,747 $10.8 Million
Q2 2018 Aug 22, 2018	BUY	$57.57 - $63.54 $7.6 Million - $8.39 Million	132,024 Added 2087.67%	138,348 $8.44 Million
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $7.62 Million - $8.41 Million	-132,314 Reduced 95.44%	6,324 $8.44 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $460,119 - $520,220	-8,177 Reduced 5.57%	138,638 $8.36 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $162,757 - $174,249	-3,032 Reduced 2.02%	146,815 $8.38 Million
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $7.2 Million - $8.04 Million	149,847	149,847 $8 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Abbott Laboratories Transaction History